NCT03158233View on ClinicalTrials.gov

Zika Case Definition and Surveillance Study

CompletedOBSERVATIONAL
Enrollment

2,400

Participants

Timeline

Start Date

April 29, 2017

Primary Completion Date

December 19, 2018

Study Completion Date

December 19, 2018

Conditions
Zika Virus Disease
Trial Locations (6)

984

Investigational Site, Carolina

11101

Investigational site, Tegucigalpa

39670

Investigational Site, Acapulco de Juárez

62587

Investigational Site, Temixco

Unknown

Investigational Site, Floridablanca

Investigational Site, Santiago de Cali

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT03158233 - Zika Case Definition and Surveillance Study | Biotech Hunter | Biotech Hunter